
1.03 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 0.70 Today|||52-Week Range 9.04 | -78.26% Year-to-Date |
Curis (CRIS) Q2 2022 Earnings Call Transcript Aug 05 / MotleyFool.com - Paid Partner Content | Curis (CRIS) Reports Q2 Loss, Tops Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
Previous close | 0.98 |
Today’s open | 0.98 |
Day’s range | 0.98 - 1.06 |
Volume | 21,710 |
Average volume (3 months) | 2,852,069 |
Market cap | $91.6M |
Earnings growth (last year) | +19.25% |
Earnings growth (this year) | -36.80% |
Earnings growth (next 5 years) | 0.00% |
Revenue growth (last year) | -1.72% |
P/E ratio | NM |
Price/Sales | 40.93 |
Price/Book | 1.01 |
Today’s change | Today’s % change | |
---|---|---|
AKTXAkari Therapeutics P... | 0.00 | 0.00% |
SLDBSolid Biosciences In... | -0.00 | -0.13% |
PNEXFPharnext SA | 0.00 | 0.00% |
SEELSeelos Therapeutics ... | +0.05 | +5.59% |
Next reporting date | November 8, 2022 |
EPS forecast (this quarter) | -$0.17 |
Annual revenue (last year) | $10.6M |
Annual profit (last year) | -$45.4M |
Net profit margin | -426.67% |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Lexington, Massachusetts |